Edema refers to the body's tissues clearance with the accumulation of excess fluid organizational swelling.Edema can be divided into systemic and local.Systemic edema (usually pitting) occurs when fluid is distributed diffusely between tissues in the body.Fluid accumulation in local interstitial space presented local edema.Occur in the body cavity called effusion, such as pleural effusion, peritoneal effusion, pericardial effusion.In general, the term edema does not include edema of the internal organs, such as cerebral edema, pulmonary edema, etc.The purpose of the edema clinical trial is to assess the efficacy of the drug delivery system, such as baseline vision and mean changes in edema.
Market Analysis and Insights: Global Edema Clinical Trials Market
The global Edema Clinical Trials market size is projected to reach US$ million by 2026, from US$ million in 2020, at a CAGR of % during 2021-2026.
Global Edema Clinical Trials Scope and Segment
The global Edema Clinical Trials market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Edema Clinical Trials market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026.
By the type, the market is primarily split into
Systemic
Local
By the application, this report covers the following segments
Hospital
Medical Research Organization
Other
Competitive Landscape:
The Edema Clinical Trials key manufacturers in this market include:
Otsuka Holdings
Roche
CMP Pharma
Syneos Health
GlaxoSmithKline
Boehringer Ingelheim
Sam Chun Dang Pharm
Endo International
Market Analysis and Insights: Global Edema Clinical Trials Market
The global Edema Clinical Trials market size is projected to reach US$ million by 2026, from US$ million in 2020, at a CAGR of % during 2021-2026.
Global Edema Clinical Trials Scope and Segment
The global Edema Clinical Trials market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Edema Clinical Trials market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026.
By the type, the market is primarily split into
Systemic
Local
By the application, this report covers the following segments
Hospital
Medical Research Organization
Other
Competitive Landscape:
The Edema Clinical Trials key manufacturers in this market include:
Otsuka Holdings
Roche
CMP Pharma
Syneos Health
GlaxoSmithKline
Boehringer Ingelheim
Sam Chun Dang Pharm
Endo International
1 Market Overview of Edema Clinical Trials
1.1 Edema Clinical Trials Market Overview
1.1.1 Edema Clinical Trials Product Scope
1.1.2 Market Status and Outlook
1.2 Global Edema Clinical Trials Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Edema Clinical Trials Market Size by Region (2015-2026)
1.4 Global Edema Clinical Trials Historic Market Size by Region (2015-2020)
1.5 Global Edema Clinical Trials Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Edema Clinical Trials Market Size YoY Growth (2015-2026)
1.6.1 North America Edema Clinical Trials Market Size YoY Growth (2015-2026)
1.6.2 Europe Edema Clinical Trials Market Size YoY Growth (2015-2026)
1.6.3 China Edema Clinical Trials Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Edema Clinical Trials Market Size YoY Growth (2015-2026)
1.6.5 Latin America Edema Clinical Trials Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Edema Clinical Trials Market Size YoY Growth (2015-2026)
2 Edema Clinical Trials Market Overview by Type
2.1 Global Edema Clinical Trials Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Edema Clinical Trials Historic Market Size by Type (2015-2020)
2.3 Global Edema Clinical Trials Forecasted Market Size by Type (2021-2026)
2.4 Systemic
2.5 Local
3 Edema Clinical Trials Market Overview by Application
3.1 Global Edema Clinical Trials Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Edema Clinical Trials Historic Market Size by Application (2015-2020)
3.3 Global Edema Clinical Trials Forecasted Market Size by Application (2021-2026)
3.4 Hospital
3.5 Medical Research Organization
3.6 Other
4 Global Edema Clinical Trials Competition Analysis by Players
4.1 Global Edema Clinical Trials Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Edema Clinical Trials as of 2019)
4.3 Date of Key Manufacturers Enter into Edema Clinical Trials Market
4.4 Global Top Players Edema Clinical Trials Headquarters and Area Served
4.5 Key Players Edema Clinical Trials Product Solution and Service
4.6 Competitive Status
4.6.1 Edema Clinical Trials Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Otsuka Holdings
5.1.1 Otsuka Holdings Profile
5.1.2 Otsuka Holdings Main Business and Company’s Total Revenue
5.1.3 Otsuka Holdings Products, Services and Solutions
5.1.4 Otsuka Holdings Revenue (US$ Million) (2015-2020)
5.1.5 Otsuka Holdings Recent Development and Reaction to Covid-19
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business and Company’s Total Revenue
5.2.3 Roche Products, Services and Solutions
5.2.4 Roche Revenue (US$ Million) (2015-2020)
5.2.5 Roche Recent Development and Reaction to Covid-19
5.3 CMP Pharma
5.5.1 CMP Pharma Profile
5.3.2 CMP Pharma Main Business and Company’s Total Revenue
5.3.3 CMP Pharma Products, Services and Solutions
5.3.4 CMP Pharma Revenue (US$ Million) (2015-2020)
5.3.5 Syneos Health Recent Development and Reaction to Covid-19
5.4 Syneos Health
5.4.1 Syneos Health Profile
5.4.2 Syneos Health Main Business and Company’s Total Revenue
5.4.3 Syneos Health Products, Services and Solutions
5.4.4 Syneos Health Revenue (US$ Million) (2015-2020)
5.4.5 Syneos Health Recent Development and Reaction to Covid-19
5.5 GlaxoSmithKline
5.5.1 GlaxoSmithKline Profile
5.5.2 GlaxoSmithKline Main Business and Company’s Total Revenue
5.5.3 GlaxoSmithKline Products, Services and Solutions
5.5.4 GlaxoSmithKline Revenue (US$ Million) (2015-2020)
5.5.5 GlaxoSmithKline Recent Development and Reaction to Covid-19
5.6 Boehringer Ingelheim
5.6.1 Boehringer Ingelheim Profile
5.6.2 Boehringer Ingelheim Main Business and Company’s Total Revenue
5.6.3 Boehringer Ingelheim Products, Services and Solutions
5.6.4 Boehringer Ingelheim Revenue (US$ Million) (2015-2020)
5.6.5 Boehringer Ingelheim Recent Development and Reaction to Covid-19
5.7 Sam Chun Dang Pharm
5.7.1 Sam Chun Dang Pharm Profile
5.7.2 Sam Chun Dang Pharm Main Business and Company’s Total Revenue
5.7.3 Sam Chun Dang Pharm Products, Services and Solutions
5.7.4 Sam Chun Dang Pharm Revenue (US$ Million) (2015-2020)
5.7.5 Sam Chun Dang Pharm Recent Development and Reaction to Covid-19
5.8 Endo International
5.8.1 Endo International Profile
5.8.2 Endo International Main Business and Company’s Total Revenue
5.8.3 Endo International Products, Services and Solutions
5.8.4 Endo International Revenue (US$ Million) (2015-2020)
5.8.5 Endo International Recent Development and Reaction to Covid-19
6 North America Edema Clinical Trials by Players and by Application
6.1 North America Edema Clinical Trials Market Size and Market Share by Players (2015-2020)
6.2 North America Edema Clinical Trials Market Size by Application (2015-2020)
7 Europe Edema Clinical Trials by Players and by Application
7.1 Europe Edema Clinical Trials Market Size and Market Share by Players (2015-2020)
7.2 Europe Edema Clinical Trials Market Size by Application (2015-2020)
8 China Edema Clinical Trials by Players and by Application
8.1 China Edema Clinical Trials Market Size and Market Share by Players (2015-2020)
8.2 China Edema Clinical Trials Market Size by Application (2015-2020)
9 Rest of Asia Pacific Edema Clinical Trials by Players and by Application
9.1 Rest of Asia Pacific Edema Clinical Trials Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Edema Clinical Trials Market Size by Application (2015-2020)
10 Latin America Edema Clinical Trials by Players and by Application
10.1 Latin America Edema Clinical Trials Market Size and Market Share by Players (2015-2020)
10.2 Latin America Edema Clinical Trials Market Size by Application (2015-2020)
11 Middle East & Africa Edema Clinical Trials by Players and by Application
11.1 Middle East & Africa Edema Clinical Trials Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Edema Clinical Trials Market Size by Application (2015-2020)
12 Edema Clinical Trials Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
1.1 Edema Clinical Trials Market Overview
1.1.1 Edema Clinical Trials Product Scope
1.1.2 Market Status and Outlook
1.2 Global Edema Clinical Trials Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Edema Clinical Trials Market Size by Region (2015-2026)
1.4 Global Edema Clinical Trials Historic Market Size by Region (2015-2020)
1.5 Global Edema Clinical Trials Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Edema Clinical Trials Market Size YoY Growth (2015-2026)
1.6.1 North America Edema Clinical Trials Market Size YoY Growth (2015-2026)
1.6.2 Europe Edema Clinical Trials Market Size YoY Growth (2015-2026)
1.6.3 China Edema Clinical Trials Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Edema Clinical Trials Market Size YoY Growth (2015-2026)
1.6.5 Latin America Edema Clinical Trials Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Edema Clinical Trials Market Size YoY Growth (2015-2026)
2 Edema Clinical Trials Market Overview by Type
2.1 Global Edema Clinical Trials Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Edema Clinical Trials Historic Market Size by Type (2015-2020)
2.3 Global Edema Clinical Trials Forecasted Market Size by Type (2021-2026)
2.4 Systemic
2.5 Local
3 Edema Clinical Trials Market Overview by Application
3.1 Global Edema Clinical Trials Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Edema Clinical Trials Historic Market Size by Application (2015-2020)
3.3 Global Edema Clinical Trials Forecasted Market Size by Application (2021-2026)
3.4 Hospital
3.5 Medical Research Organization
3.6 Other
4 Global Edema Clinical Trials Competition Analysis by Players
4.1 Global Edema Clinical Trials Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Edema Clinical Trials as of 2019)
4.3 Date of Key Manufacturers Enter into Edema Clinical Trials Market
4.4 Global Top Players Edema Clinical Trials Headquarters and Area Served
4.5 Key Players Edema Clinical Trials Product Solution and Service
4.6 Competitive Status
4.6.1 Edema Clinical Trials Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Otsuka Holdings
5.1.1 Otsuka Holdings Profile
5.1.2 Otsuka Holdings Main Business and Company’s Total Revenue
5.1.3 Otsuka Holdings Products, Services and Solutions
5.1.4 Otsuka Holdings Revenue (US$ Million) (2015-2020)
5.1.5 Otsuka Holdings Recent Development and Reaction to Covid-19
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business and Company’s Total Revenue
5.2.3 Roche Products, Services and Solutions
5.2.4 Roche Revenue (US$ Million) (2015-2020)
5.2.5 Roche Recent Development and Reaction to Covid-19
5.3 CMP Pharma
5.5.1 CMP Pharma Profile
5.3.2 CMP Pharma Main Business and Company’s Total Revenue
5.3.3 CMP Pharma Products, Services and Solutions
5.3.4 CMP Pharma Revenue (US$ Million) (2015-2020)
5.3.5 Syneos Health Recent Development and Reaction to Covid-19
5.4 Syneos Health
5.4.1 Syneos Health Profile
5.4.2 Syneos Health Main Business and Company’s Total Revenue
5.4.3 Syneos Health Products, Services and Solutions
5.4.4 Syneos Health Revenue (US$ Million) (2015-2020)
5.4.5 Syneos Health Recent Development and Reaction to Covid-19
5.5 GlaxoSmithKline
5.5.1 GlaxoSmithKline Profile
5.5.2 GlaxoSmithKline Main Business and Company’s Total Revenue
5.5.3 GlaxoSmithKline Products, Services and Solutions
5.5.4 GlaxoSmithKline Revenue (US$ Million) (2015-2020)
5.5.5 GlaxoSmithKline Recent Development and Reaction to Covid-19
5.6 Boehringer Ingelheim
5.6.1 Boehringer Ingelheim Profile
5.6.2 Boehringer Ingelheim Main Business and Company’s Total Revenue
5.6.3 Boehringer Ingelheim Products, Services and Solutions
5.6.4 Boehringer Ingelheim Revenue (US$ Million) (2015-2020)
5.6.5 Boehringer Ingelheim Recent Development and Reaction to Covid-19
5.7 Sam Chun Dang Pharm
5.7.1 Sam Chun Dang Pharm Profile
5.7.2 Sam Chun Dang Pharm Main Business and Company’s Total Revenue
5.7.3 Sam Chun Dang Pharm Products, Services and Solutions
5.7.4 Sam Chun Dang Pharm Revenue (US$ Million) (2015-2020)
5.7.5 Sam Chun Dang Pharm Recent Development and Reaction to Covid-19
5.8 Endo International
5.8.1 Endo International Profile
5.8.2 Endo International Main Business and Company’s Total Revenue
5.8.3 Endo International Products, Services and Solutions
5.8.4 Endo International Revenue (US$ Million) (2015-2020)
5.8.5 Endo International Recent Development and Reaction to Covid-19
6 North America Edema Clinical Trials by Players and by Application
6.1 North America Edema Clinical Trials Market Size and Market Share by Players (2015-2020)
6.2 North America Edema Clinical Trials Market Size by Application (2015-2020)
7 Europe Edema Clinical Trials by Players and by Application
7.1 Europe Edema Clinical Trials Market Size and Market Share by Players (2015-2020)
7.2 Europe Edema Clinical Trials Market Size by Application (2015-2020)
8 China Edema Clinical Trials by Players and by Application
8.1 China Edema Clinical Trials Market Size and Market Share by Players (2015-2020)
8.2 China Edema Clinical Trials Market Size by Application (2015-2020)
9 Rest of Asia Pacific Edema Clinical Trials by Players and by Application
9.1 Rest of Asia Pacific Edema Clinical Trials Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Edema Clinical Trials Market Size by Application (2015-2020)
10 Latin America Edema Clinical Trials by Players and by Application
10.1 Latin America Edema Clinical Trials Market Size and Market Share by Players (2015-2020)
10.2 Latin America Edema Clinical Trials Market Size by Application (2015-2020)
11 Middle East & Africa Edema Clinical Trials by Players and by Application
11.1 Middle East & Africa Edema Clinical Trials Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Edema Clinical Trials Market Size by Application (2015-2020)
12 Edema Clinical Trials Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
